Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
07 2019
Historique:
received: 03 01 2019
accepted: 17 06 2019
revised: 25 07 2019
pubmed: 16 7 2019
medline: 3 1 2020
entrez: 16 7 2019
Statut: epublish

Résumé

The HIV-1 envelope glycoprotein (Env) trimer is located on the surface of the virus and is the target of broadly neutralizing antibodies (bNAbs). Recombinant native-like soluble Env trimer mimetics, such as SOSIP trimers, have taken a central role in HIV-1 vaccine research aimed at inducing bNAbs. We therefore performed a direct and thorough comparison of a full-length unmodified Env trimer containing the transmembrane domain and the cytoplasmic tail, with the sequence matched soluble SOSIP trimer, both based on an early Env sequence (AMC011) from an HIV+ individual that developed bNAbs. The structures of the full-length AMC011 trimer bound to either bNAb PGT145 or PGT151 were very similar to the structures of SOSIP trimers. Antigenically, the full-length and SOSIP trimers were comparable, but in contrast to the full-length trimer, the SOSIP trimer did not bind at all to non-neutralizing antibodies, most likely as a consequence of the intrinsic stabilization of the SOSIP trimer. Furthermore, the glycan composition of full-length and SOSIP trimers was similar overall, but the SOSIP trimer possessed slightly less complex and less extensively processed glycans, which may relate to the intrinsic stabilization as well as the absence of the membrane tether. These data provide insights into how to best use and improve membrane-associated full-length and soluble SOSIP HIV-1 Env trimers as immunogens.

Identifiants

pubmed: 31306470
doi: 10.1371/journal.ppat.1007920
pii: PPATHOGENS-D-18-02470
pmc: PMC6658011
doi:

Substances chimiques

Broadly Neutralizing Antibodies 0
HIV Antibodies 0
HIV Antigens 0
Polysaccharides 0
Recombinant Proteins 0
env Gene Products, Human Immunodeficiency Virus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1007920

Subventions

Organisme : NIAID NIH HHS
ID : F31 AI131873
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI110657
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI100663
Pays : United States

Déclaration de conflit d'intérêts

The authors have no competing interests.

Références

J Virol. 2015 Jul;89(13):6952-9
pubmed: 25878100
PLoS Pathog. 2015 Mar 25;11(3):e1004767
pubmed: 25807248
Immunity. 2017 Jun 20;46(6):1073-1088.e6
pubmed: 28636956
Science. 2016 Mar 4;351(6277):1043-8
pubmed: 26941313
Nat Struct Mol Biol. 2015 Jul;22(7):522-31
pubmed: 26098315
PLoS Pathog. 2013 Sep;9(9):e1003618
pubmed: 24068931
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Elife. 2018 Nov 09;7:
pubmed: 30412051
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):E3268-77
pubmed: 23115339
PLoS Pathog. 2015 Jan 08;11(1):e1004570
pubmed: 25569572
Nat Commun. 2017 Nov 21;8(1):1655
pubmed: 29162799
J Virol. 2015 Sep;89(17):8932-44
pubmed: 26085151
Immunity. 2015 Dec 15;43(6):1053-63
pubmed: 26682982
J Virol. 2017 Jan 3;91(2):
pubmed: 27807235
Cell Rep. 2018 Jun 12;23(11):3249-3261
pubmed: 29898396
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Virol. 2015 Dec;89(23):12189-210
pubmed: 26311893
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Immunity. 2014 May 15;40(5):669-80
pubmed: 24768348
J Mol Biol. 2012 Jan 13;415(2):406-18
pubmed: 22100448
J Struct Biol. 2009 May;166(2):205-13
pubmed: 19374019
Science. 2011 Nov 25;334(6059):1097-103
pubmed: 21998254
J Virol. 2002 Sep;76(17):8875-89
pubmed: 12163607
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12111-6
pubmed: 22773820
Nat Struct Mol Biol. 2013 Jul;20(7):796-803
pubmed: 23708606
Nature. 2014 Oct 23;514(7523):455-61
pubmed: 25296255
Science. 2013 Dec 20;342(6165):1484-90
pubmed: 24179160
Nat Commun. 2018 Sep 12;9(1):3693
pubmed: 30209313
Cell Rep. 2017 Aug 22;20(8):1805-1817
pubmed: 28834745
Immunol Rev. 2017 Jan;275(1):161-182
pubmed: 28133806
Cell. 2016 May 5;165(4):813-26
pubmed: 27114034
J Virol. 2010 Feb;84(3):1302-13
pubmed: 19906907
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11483-8
pubmed: 20534513
Science. 2015 Jul 10;349(6244):aac4223
pubmed: 26089353
J Virol. 2000 Jan;74(2):627-43
pubmed: 10623724
Curr Opin HIV AIDS. 2018 Mar;13(2):128-136
pubmed: 29266013
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2641-6
pubmed: 16481622
Science. 2016 May 13;352(6287):828-33
pubmed: 27174988
PLoS Pathog. 2013;9(5):e1003342
pubmed: 23658524
Curr Opin HIV AIDS. 2009 Sep;4(5):347-51
pubmed: 20048696
PLoS Pathog. 2017 Feb 22;13(2):e1006212
pubmed: 28225819
Science. 2013 Dec 20;342(6165):1477-83
pubmed: 24179159
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18921-5
pubmed: 23100539
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
J Virol. 2015 Mar;89(6):3380-95
pubmed: 25589637
PLoS Pathog. 2009 May;5(5):e1000433
pubmed: 19436712
Cell Rep. 2018 Aug 21;24(8):1958-1966.e5
pubmed: 30134158
Cell Rep. 2015 Jun 16;11(10):1604-13
pubmed: 26051934
J Struct Biol. 2003 Jun;142(3):334-47
pubmed: 12781660
PLoS Pathog. 2016 Sep 14;12(9):e1005864
pubmed: 27627672
Nat Microbiol. 2016 Nov 14;2:16199
pubmed: 27841852
Immunity. 2017 Apr 18;46(4):690-702
pubmed: 28423342
Cell. 2015 Dec 17;163(7):1702-15
pubmed: 26687358
Cell Rep. 2016 Mar 22;14(11):2695-706
pubmed: 26972002
Annu Rev Biophys. 2018 Mar 29;:
pubmed: 29595997
Curr Opin Struct Biol. 2017 Jun;44:125-133
pubmed: 28363124
Nat Med. 2000 Feb;6(2):207-10
pubmed: 10655111
Cell. 2015 Sep 10;162(6):1379-90
pubmed: 26359989
AIDS. 2014 May 15;28(8):1237-40
pubmed: 24556870
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

Alba Torrents de la Peña (A)

Department of Medical Microbiology, Amsterdam UMC - University of Amsterdam, Amsterdam, the Netherlands.

Kimmo Rantalainen (K)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.

Christopher A Cottrell (CA)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.

Joel D Allen (JD)

Centre for Biological Sciences & Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.

Marit J van Gils (MJ)

Department of Medical Microbiology, Amsterdam UMC - University of Amsterdam, Amsterdam, the Netherlands.

Jonathan L Torres (JL)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.

Max Crispin (M)

Centre for Biological Sciences & Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.

Rogier W Sanders (RW)

Department of Medical Microbiology, Amsterdam UMC - University of Amsterdam, Amsterdam, the Netherlands.

Andrew B Ward (AB)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH